Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2026-05-02 @ 8:59 PM
Study NCT ID:
NCT04987320
Status:
COMPLETED
Last Update Posted:
2025-02-10
First Post:
2021-07-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a)
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
20190095
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None